Four Arnold & Porter Lawyers Named to Law360’s 2026 Editorial Advisory Boards

Four Arnold & Porter lawyers were recently named to Law360’s 2026 Editorial Advisory Boards in the areas of Compliance, Government Contracts, Health Care, and Product Liability.

Law360’s Editorial Advisory Boards provide feedback on its coverage and produce expert insight on how to shape the publication’s future coverage.

The following lawyers were named to the publication’s 2026 Editorial Advisory Boards:

• Frank Cruz-Alvarez was named to Law360’s Product Liability Editorial Board. Frank, a partner in the firm’s Litigation - Product Liability and Mass Tort practice group, is a trial lawyer with more than 20 years of experience representing companies and individuals in a variety of complex domestic and international disputes. He has represented numerous Fortune 100 companies, serving in several capacities from pretrial counselor to trial and appellate counsel, and is regularly retained to provide strategic advice to trial teams, and briefs and argues complex issues in high-stakes trials and appeals. 
• Kristen Ittig was named to Law360’s Government Contracts Editorial Board. Kristen, a partner in the firm’s Government Contracts practice group, counsels and represents clients in government contracts matters, including compliance counseling, bid protests, investigations, audits and self-disclosures, claims and disputes, terminations, and other issues impacting government contractors and federal grantees. She advises companies on negotiation of bespoke funding agreements and assists companies in designing and implementing effective compliance programs. 
• Liz Lindquist was named to Law360’s Compliance Editorial Board. Liz, a partner in the firm’s Life Sciences and Healthcare Regulatory practice group, counsels clients on a broad range of federal and state regulatory, fraud and abuse, and compliance matters. Liz routinely assists multinational companies with sensitive internal investigations and government enforcement matters, and she has particular experience advising clients on complex pharmaceutical market access and price calculation and reporting issues that overlap with other business-critical substantive areas, including federal contracting, international trade, and SEC compliance obligations.
• Allison Shuren was named to Law360’s Health Care Editorial Board. Allison, co-chair of the firm’s Life Sciences & Healthcare Regulatory practice, is a recognized leader in healthcare, advising a wide range of healthcare, life science, and digital health clients on regulatory, compliance, and False Claims Act enforcement. A primary focus of Allison’s practice is compliance with health regulatory requirements, especially the healthcare fraud and abuse laws. Clients seek her counsel on complex business arrangements plan, key transactions, and high-stakes government investigations.